Bridgebio Pharma, Inc. · NASDAQ:BBIO

Viking Global Investors LP reported a 9.80% stake in Bridgebio Pharma, Inc. (Schedule 13D/A)

Event Jun 27, 2025 · Filed Jul 1, 2025

Viking Global Investors LP reported a 9.80% stake in Bridgebio Pharma, Inc., 18,602,920 shares, with active intent on Jun 27, 2025. Filed Jul 1, 2025 (Schedule 13D/A).

Stake: 9.80%
Shares: 18,602,920
Intent: Active
What changed: Stake changed
Filed together: 14 holders

The filing in full

Holder	Stake	Shares
VIKING GLOBAL INVESTORS LP	9.80%	18,602,920
VIKING GLOBAL PERFORMANCE LLC	0.20%	339,695
Viking Global Equities II LP	0%	6,794
Viking Global Equities Master Ltd.	0.20%	332,901
Viking Long Fund GP LLC	0.10%	118,214
Viking Long Fund Master Ltd.	0.10%	118,214
Viking Global Opportunities Parent GP LLC	9.60%	18,145,011
Viking Global Opportunities GP LLC	9.60%	18,145,011
Viking Global Opportunities Portfolio GP LLC	9.60%	18,145,011
Viking Global Opportunities Illiquid Investments Sub-Master LP	9.50%	18,089,980
Viking Global Opportunities Liquid Portfolio Sub-Master LP	0.03%	55,031
HALVORSEN OLE ANDREAS	9.80%	18,602,920
Ott David C.	9.80%	18,602,920
Shabet Rose Sharon	9.80%	18,602,920

Source

View original at SEC

Related